TF and neoplasm: Functionalization with targeting ligands such as folate, RGD (Arginine-Glycine-Aspartic acid) peptides [19], and transferrin has further enhanced their specificity, allowing for tumor targeting, blood-brain barrier (BBB) penetration [20], and site-specific therapy [21].